Bavarian Nordic A/S

Africa CDC Strengthens Mpox Response with Additional Vaccine Support

The Africa Centres for Disease Control and Prevention (Africa CDC) has strengthened its mpox response with an additional donation of 110,000 doses of mpox vaccines from Bavarian Nordic. The vaccines have been allocated to Uganda through the Mpox Access and Allocation Mechanism (AAM), coordinated by Africa CDC in collaboration

Bavarian Nordic A/S

WHO Approves First Vaccine for Mpox Virus as Outbreak Continues

The World Health Organization (WHO) has approved the first vaccine for the mpox virus, MVA-BN, in a bid to contain the ongoing outbreak. The vaccine has been added to WHO's prequalification list, making it available to communities in urgent need. The vaccine has shown an estimated 76% effectiveness